Publisher
Springer Science and Business Media LLC
Reference53 articles.
1. WHO. Leishmaniasis in high-burden countries: an epidemiological update based on data reported in 2014. Wkly. Epidemiol. Rec. 91, 287–296 (2016).
2. Shakya, N., Bajpai, P. & Gupta, S. Therapeutic switching in Leishmania chemotherapy: a distinct approach towards unsatisfied treatment needs. J Parasit Dis 35, 104–112 (2011).
3. Charlton, R. L., Rossi-Bergmann, B., Denny, P. W. & Steel, P. G. Repurposing as a strategy for the discovery of new anti-leishmanials: the-state-of-the-art. Parasitology 145, 219–236 (2018).
4. Welay, G. M., Alene, K. A. & Dachew, B. A. Visceral leishmaniasis treatment outcome and its determinants in northwest Ethiopia. Epidemiol Health 39, e2017001 (2016).
5. Sundar, S. & Chakravarty, J. Antimony toxicity. Int J Environ Res Public Health 7, 4267–4277 (2010).
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献